Hear from expert oncologists and pathologists how NGS-based comprehensive genomic profiling assays are changing the paradigm in oncology. On Demand recordings of ESMO Industry Satellite Symposium.
Phil Febbo
Chief Medical Officer
Illumina
Bernard Dogerde Spéville
Medical Oncologist
Fundación Jiménez Díaz
Wilko Weichert
Prof of Pathology
Technical University Munich
귀하의 이메일 주소는 결코 제3자와 공유되지 않습니다.